Pathological anatomy and molecular pathology

被引:11
作者
Krismann, M
Müller, KM
Jaworska, M
Johnen, G
机构
[1] Univ Clin Bergmannsheil Bochum, Inst Pathol, D-44789 Bochum, Germany
[2] Univ Clin Bergmannsheil Bochum, German Mesothelioma Registry, D-44789 Bochum, Germany
关键词
mesothelioma; telomerase reverse transcriptase catalytic subunit (TERT); DNA cytometric analysis; comparative genomic hybridization; immunohistochemical analysis; Simian virus 40; mesodermoma;
D O I
10.1016/j.lungcan.2004.04.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The incidence of malignant mesotheliomas in Germany has increased since about the mid 1980s, and a further increase is expected until about 2020 due to the peak in asbestos processing in Germany between 1965 and 1980. About 90% of the mesotheliomas recorded in the files of the German Mesothelioma Registry in, Bochum are asbestos-related and therefore possibly due to an occupational exposure. In 2003, 717 mesotheliomas were newly diagnosed at the German Mesothelioma Registry. Mesotheliomas are very heterogeneous in terms of histological appearances and of prognosis. At present, the diagnostic gold standard is conventional histology in combination with additional immunohistochemical analysis. We were not able to confirm a promising report that described telomerase reverse transcriptase catalytic subunit (TERT) for the differentiation between reactive and neoplastic mesothelial lesions, which can be extremely difficult. DNA cytometric analysis may also help differentiate between reactive and neoplastic mesothelial lesions. There are some characteristic patterns of chromosomal imbalances as detectable by comparative genomic hybridization (CGH), but at present, specific chromosomal or genetic defects that give rise to a mesothelioma are not known. A retiable pathological diagnosis is the basis for therapeutic, prognostic, and medicole-gal consequences. In general, it can be achieved by thoracoscopic inspection with specifically directed biopsy. Furthermore, a description of the peculiarities of each mesothelioma by the pathologist might be the key to a more individual therapy in the future. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S29 / S33
页数:5
相关论文
共 25 条
[1]  
BARIS I, 1979, ANN NY ACAD SCI, V330, P432
[2]  
Battifora H, 1995, TUMOURS SEROSAL MEMB
[3]   Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung [J].
Björkqvist, AM ;
Tammilehto, L ;
Nordling, S ;
Nurminen, M ;
Anttila, S ;
Mattson, K ;
Knuutila, S .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :260-269
[4]   Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma [J].
Bjorkqvist, AM ;
Tammilehto, L ;
Anttila, S ;
Mattson, K ;
Knuutila, S .
BRITISH JOURNAL OF CANCER, 1997, 75 (04) :523-527
[5]  
CARBONE M, 1994, ONCOGENE, V9, P1781
[6]   MESODERMOMAS - A NEW EMBRYOLOGICAL APPROACH TO PRIMARY TUMORS OF CELOMIC SURFACES [J].
DONNA, A ;
BETTA, PG .
HISTOPATHOLOGY, 1981, 5 (01) :31-44
[7]   DIFFERENTIATION TOWARDS CARTILAGE AND BONE IN A PRIMARY TUMOR OF PLEURA - FURTHER EVIDENCE IN SUPPORT OF THE CONCEPT OF MESODERMOMA [J].
DONNA, A ;
BETTA, PG .
HISTOPATHOLOGY, 1986, 10 (01) :101-108
[8]   A NEW INSIGHT INTO THE HISTOGENESIS OF MESODERMOMAS - MALIGNANT MESOTHELIOMAS [J].
DONNA, A ;
BETTA, PG ;
BIANCHI, V ;
RIBOTTA, M ;
BELLINGERI, D ;
ROBUTTI, F ;
MARCHESINI, A .
HISTOPATHOLOGY, 1991, 19 (03) :239-243
[9]  
HAMMAR SP, PULMONARY PATHOLOGY, P1487
[10]  
HUZLY A, 1989, Z HERZ THORAX GEFASS, V3, P80